26 reports

  • APPENDIX: SKIN CANCER
  • TYPES AND SYMPTOMS OF SKIN CANCER

FACTORS THAT LEAD TO SKIN CANCER ARE OVER EXPOSURE TO UV (ULTRA-VIOLET SUN RAYS); UNUSUAL / LARGE SHAPED MOLES ON THE BODY; SENSITIVE SKIN THAT BURNS EASILY; SKIN CONDITIONS SUCH AS ECZEMA; WEAK IMMUNE SYSTEM OR CLOSED ONES WHO HAVE SKIN

  • Skin Cancer
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • Skin Cancer Awareness
  • GLOBAL SKIN CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

Economic Increase in Healthcare Budget Skin cancer awareness is a need of an hour as Africa is one of the highest skin cancer rates across the global.

  • Skin Cancer
  • World
  • Forecast
  • Market Size
  • Avita Medical Ltd.
  • Market Size
  • CHAPTER III SKIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

THE MOST COMMON SKIN CANCERS ARE BASAL CELL CANCER (BCC), SQUAMOUS CELL CANCER (SCC), AND MELANOMA.

  • Skin Cancer
  • China
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Zhejiang Expressway Co., Ltd.
  • Skin Cancer Treatment Drugs Sales Volume by Type
  • CHAPTER IV SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

THE MOST COMMON SKIN CANCERS ARE BASAL CELL CANCER, SQUAMOUS CELL CANCER, AND MELANOMA.

  • Skin Cancer
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • PRESCRIPTION SKIN CANCER PREPARATIONS IN DEVELOPMENT
  • 11: Prescription Skin Cancer Drugs

STATISTICALLY, ONE IN FIVE AMERICANS WILL DEVELOP SKIN CANCER IN THEIR LIFETIME.

  • Skin Cancer
  • World
  • Market Size
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.
  • MULTISPECTRAL IMAGING (MSI) SYSTEM PRODUCT OVERVIEW
  • OCT 01, 2014: VERISANTE TECHNOLOGY ANNOUNCES SUBMISSION TO THE FDA FOR AURA, A SKIN CANCER DETECTION DEVICE

Melanoma, the deadliest form of skin cancer, accounts for one death every ## minutes in the United States.

  • Cancer
  • Skin Cancer
  • Canada
  • United States
  • Verisante Technology, Inc.

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Skin Cancer
  • France
  • Germany
  • United States
  • Market Size
  • MARKET SEGMENTATION - BY TREATMENT
  • SKIN CANCER DIAGNOSTICS AND THERAPEUTICS MARKET

As per the estimates of the Skin Cancer Foundation, one in every five Americans is likely to develop a kind of skin cancer during his/ her lifetime.

  • Skin Cancer
  • United States
  • Abbott Laboratories, Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Skin Cancer Treatment Drugs Sales Volume by Type
  • CHAPTER IV SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

The most common skin cancers are basal cell cancer, squamous cell cancer, and melanoma.

  • Skin Cancer
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Skin Cancer
  • France
  • Germany
  • Italy
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • Japan
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • United States
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • Italy
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • Germany
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • France
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • United Kingdom
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • Spain
  • Market Size

Skin Cancer Global Clinical Trials Review, H##, 2020 List of Tables List of Figures Report Guidance GlobalData Clinical Trials Report Coverage Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Five Countries Contributing to Clinical Trials in Asia-Pacif

  • Cancer
  • Clinical Trial
  • Drug Development
  • Skin Cancer
  • World
  • 2.1 INTRODUCTION TO SKIN CANCER
  • 2.1 INTRODUCTION TO SKIN CANCER

FIGURE ##: TYPES OF SKIN CANCER Different types of skin cells cause different types of skin cancers.

  • Skin Cancer
  • Biopharmaceuticals Inc.
  • Merck & Co., Inc.
  • Navidea Biopharmaceuticals, Inc.
  • SciBase Company

Skin Cancer Global Clinical Trials Review, H##, 2018 Table of Contents ## List of Tables ## List of Figures ## Report Guidance ## GlobalData Clinical Trials Report Coverage ## Clinical Trials by Region ## Clinical Trials and Average Enrollment by Country ## Top Five Countries Contributing

  • Cancer
  • Clinical Trial
  • Drug Development
  • Skin Cancer
  • World

Global Skin Cancer Vaccine Market & Pipeline Insight 2015 ##.

  • Skin Cancer
  • Therapy
  • Vaccine
  • World
  • Forecast
  • Clinical Trial profile. 5 Trial Title
  • Clinical Trial profile. 125 Trial Title

Veracity has run many skin cancer studies and has prior experience with PDT treatment.

  • Clinical Trial
  • Skin Cancer
  • Therapy
  • World
  • Product Initiative
  • HANDHELD RCM/OCT PROBE - SKIN CANCER
  • Handheld RCM/OCT Probe - Skin Cancer - Product Status

Jul ##, 2015: PSI' s Hand-held RCM/ OCT Probe for Skin Cancer Laser Therapy Guidance In collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) and Caliber Imaging & Diagnostics Inc.

  • Medical Device
  • Skin Cancer
  • United States
  • APR 29, 2016: NICE RECOMMENDS COMBINED DRUG THERAPY PROVEN TO EXTEND LIFE FOR SKIN CANCER
  • FEB 25, 2016: NEW TARGETED THERAPY FOR TREATMENT OF SERIOUS FORM OF SKIN CANCER APPROVED IN CANADA

Adil Daud, University of California, San Francisco, San Francisco, California Poster Session: Melanoma/ Skin Cancers Poster presentation from Saturday, June ##, ## - ##:## p. m.

  • Cancer
  • Skin Cancer
  • Targeted Therapy
  • United States
  • Novartis AG
  • APR 29, 2016: NICE RECOMMENDS COMBINED DRUG THERAPY PROVEN TO EXTEND LIFE FOR SKIN CANCER
  • FEB 25, 2016: NEW TARGETED THERAPY FOR TREATMENT OF SERIOUS FORM OF SKIN CANCER APPROVED IN CANADA

Adil Daud, University of California, San Francisco, San Francisco, California Poster Session: Melanoma/ Skin Cancers Poster presentation from Saturday, June ##, ## - ##:## p. m.

  • Cancer
  • Skin Cancer
  • Targeted Therapy
  • United States
  • Novartis AG
  • Clinical Trial profile. 108 Trial Title
  • Clinical Trial profile. 117 Trial Title

## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## ## Japan Source: Glob

  • Cancer
  • Skin Cancer
  • Therapy
  • World
  • Product Initiative